Bigtincan Holdings Limited

BTH

AU000000BTH6

Biotechnology & Medical Research

Delayed Australian S.E. Other stock markets 09:01:42 06/06/2024 am IST			5-day change	1st Jan Change
0.14 ^AUD	0.00%		0.00%	-30.00%

11/04	Bigtincan Holdings Logs AU$30 Million Revenue in Fiscal Q3; Shares Surge 19%	MT
18/03	Bigtincan Holdings Limited(ASX:BTH) dropped from S&P/ASX All Ordinaries Index	CI

Bigtincan Announces Death of Geoffrey P Cohen, Cofounder and Director

December 06, 2017 at 04:36 am IST

Bigtincan announced the passing of Dr. Geoffrey (Geoff) P Cohen after a short Illness. Geoff was a Cofounder and Director of Bigtincan.

Latest news about Bigtincan Holdings Limited

Bigtincan Holdings Logs AU$30 Million Revenue in Fiscal Q3; Shares Surge 19%	11/04	MT
Bigtincan Holdings Limited(ASX:BTH) dropped from S&P/ASX All Ordinaries Index	18/03	CI
Bigtincan Shares Shed 11% as Fiscal H1 Revenue Contracts 1.5%; Loss Narrows	28/02	MT
Transcript : Bigtincan Holdings Limited, H1 2024 Earnings Call, Feb 27, 2024	28/02
Bigtincan Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02	CI
Transcript : Bigtincan Holdings Limited - Shareholder/Analyst Call	29/11
Bigtincan Holdings Limited Provides Earnings Guidance for the Fiscal Year 2024	15/11	CI
Bigtincan Holdings Limited Announces Resignation of Farouk Hussein as Non-Executive Director	03/23/03	CI
Bigtincan Holdings Limited(ASX:BTH) dropped from S&P Global BMI Index	18/23/18	CI
Bigtincan Reportedly Say It Remains in Takeover Talks	18/23/18	CI
Bigtincan Holdings Launches Cost Reduction Program	15/23/15	MT
Transcript : Bigtincan Holdings Limited, 2023 Earnings Call, Aug 30, 2023	31/23/31
Bigtincan Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/23/31	CI
Bigtincan to Borrow AU$15 Million to Grow AI Technology	21/23/21	MT
Bigtincan Holdings Limited Provides Financial Results Outlook for Fiscal Year 2023	21/23/21	CI
Transcript : Bigtincan Holdings Limited - Special Call	22/23/22
Bigtincan Holdings Limited Launches GenieAI Technology, Delivering Transformational Sales Productivity Gains to Customers	13/23/13	CI
Bigtincan Holdings Limited Provides Earnings Guidance for the Year 2023	13/23/13	CI
Transcript : Bigtincan Holdings Limited, H1 2023 Earnings Call, Feb 27, 2023	27/23/27
Bigtincan Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2022	27/23/27	CI
Bigtincan Appoints Morgan Stanley to Evaluate Interest it Received from Potential Buyers	17/23/17	CI
Bigtincan Acquires Revenue Data Capture Platform SalesDirector.ai	28/22/28	MT
Bigtincan's New Relationship Intelligence Technology Unlocks Value Hidden in Relationship Networks	13/22/13	CI
Bigtincan Holdings to Seek M&A	08/22/08	CI
Bigtincan completes capital raising despite suitor SQN Investors' concerns	08/22/08	RE

Chart Bigtincan Holdings Limited

Duration

Period

More charts

Beta Pharmaceutical Limited is a Australia-based biopharmaceutical company. The Company is focused on the identification, development and commercialization of products and therapies targeting the chemoprevention and treatment of breast cancer. The Company is working in collaboration with scientists at the College of Pharmacy, University of Louisiana at Monroe in southern the United States of America (ULM) to develop cancer chemopreventive agents using natural phytonutrients, called tocotrienols as treatments for breast cancers. Funded by Beta Pharmaceutical Limited, the applied research programme with ULM includes four laboratories and is known as the Breast Cancer and Health Project, which has been underway.

Sector

Biotechnology & Medical Research

Calendar

27/08/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Bigtincan Holdings Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.14 AUD

Average target price

0.39 AUD

Spread / Average Target

+178.57%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
BIGTINCAN HOLDINGS LIMITED	-30.00%	57.35M
MODERNA, INC.	+55.70%	55.7B
LONZA GROUP AG	+41.08%	39.91B
IQVIA HOLDINGS INC.	-5.39%	39.57B
CELLTRION, INC.	-5.56%	28.16B
ICON PUBLIC LIMITED COMPANY	+16.46%	26.3B
ALNYLAM PHARMACEUTICALS, INC.	-20.56%	18.94B
MEDPACE HOLDINGS, INC.	+33.03%	12.17B
UNITED THERAPEUTICS CORPORATION	+25.85%	12.12B
BIO-TECHNE CORPORATION	+2.72%	12.12B

Other Biotechnology & Medical Research

Bigtincan Holdings Limited

Equities

BTH

AU000000BTH6

Biotechnology & Medical Research

Bigtincan Announces Death of Geoffrey P Cohen, Cofounder and Director

Latest news about Bigtincan Holdings Limited

Chart Bigtincan Holdings Limited

Company Profile

Income Statement Evolution

Ratings for Bigtincan Holdings Limited

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Other Biotechnology & Medical Research